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COPDAbstract Background: Handling of inhaler devices in actual Egyptian pulmonary clinical care
practice is not well studied. This study aims at performing checklist audit regarding the Egyptian
patients’ usage technique of the inhalation devices.
Methods: Asthma or chronic obstructive pulmonary disease (COPD) patients using any type of
inhaler devices in 9 various health services in 3 different Egyptian governorates were recruited dur-
ing the period between April 2011 and June 2012. Patients were asked to demonstrate their inhaler
techniques and errors were recorded against inhaler-speciﬁc checklists. Then patients were inter-
viewed regarding their knowledge of inhalation devices.
Results: We included 533 patients (71.9% asthma and 28.1% COPD). Pressurized metered dose
inhalers (MDI), Diskus, aerolizer/handihaler and turbuhaler were used by 70.5%, 10.5%, 14.1%
and 4.9% of patients, respectively. More than 99% of asthma and COPD patients claimed to know
how to use the inhaled devices. One error at least in all and essential inhalation steps was committed
in 91.7% and 35.8% of the patients, respectively. Among essential steps, Diskus inhaler had the
lowest rate of incorrect handling (7.1%) and MDI had the highest rate of incorrect handling
(44.7%). MDI use was associated with a signiﬁcant higher rate of incorrect technique than other
devices. COPD group patients committed non-signiﬁcant more errors than did the asthma group
patients when using MDI or aerolizer/handihaler.
Conclusions: Improper inhaler technique is common among our patients. Discrepancy between
patients understanding and actual usage technique of different inhalation devices was noted.
ª 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Background
Nowadays the most common chronic airway diseases, such as
asthma and chronic obstructive pulmonary disease (COPD),
aremainly treated by inhaled therapy [1–3]. Inhaledmedications
Table 1 Demographics and characteristics of the patients,
inhaled devices and physicians.
Age,# (years) 49.6 ± 14.2 (18–83)
Sex, (M/F) (%) 52.6/47.4
Duration of usage in days# 2015.4 ± 2234.2 (30–15330)
Diagnosis (%)
Asthma 71.9
COPD 28.1
Type of practice (%)
Private 52.7
OPC state funded hospital 37
Inpatient state funded hospital 10.3
Type of device
MDI 376 (70.5%)
Diskus 56 (10.5%)
Aerolizer/handihaler 75 (14.1%)
Turbuhaler 26 (4.9%)
Treating physician (%)
Pulmonologist 91.7
GP 6.2
Internist 1.7
Allergologist 0.4
498 A. Madkour, I. Galalare administered directly to the airways, providing a higher local
concentration and a lower risk of systemic side effects [1].
Unfortunately the physician often simply prescribes inhaler
therapy, taking for granted that the patient will carry it out
properly, whereas the majority of patients do not realize that
the efﬁcacy of inhaler therapy often depends onwhether it is car-
ried out correctly [4].
It is most important that physicians choose the technique
best suited to each patient [5]. Studies have shown that at least
half of all adult patients are probably obtaining little or no
beneﬁt from conventional pressurized inhalers because of
incorrect inhalation technique [6,7]. While, others announce
that only one in ﬁve patients uses their inhaler properly [8].
Teaching patients how to use devices appropriately can be cru-
cial. Patient technique is inﬂuenced by factors such as patient
experience, education, physical ability and effective teaching of
technique [9].
Inhalation device had been introduced in Egypt since a long
period and in the recent years a new variety of devices are avail-
able in the market, but still limited information in the literature
is available about the patients’ correct usage technique. Thus,
this study aims at performing checklist audit regarding the
Egyptian patients’ usage technique of the inhalation devices.COPD, chronic obstructive pulmonary disease; GP, general prac-
titioner; MDI, metered dose inhaler; OPC, outpatient clinic.
# Data in parentheses represent range.Methods
This prospective observational study was conducted in 3 dif-
ferent Egyptian governorates (Cairo, Dakahlia and Qena)
and 9 various health services including 5 private clinics in
Cairo and 4 state funded services: one university hospital
(Ain Shams University Hospitals, Cairo), 3 tertiary care hospi-
tals [Sherbin Chest Hospital {Dakahlia}, Shobrahour Chest
Hospital {Dakahlia}, Qena Chest Hospital {Qena}], in an
attempt to present various socioeconomic and health care sec-
tors in Egypt.
Consecutive adult (P18 year old) stable patients receiving
service in the above mentioned health services during the peri-
od between April 2011 and June 2012 and using any type of
inhaler devices for at least one month were included in the
study. Study population was conﬁned to asthma and COPD
patients as they represent nearly all patients who used inhaler
devices during study period. The patients were deﬁned of hav-
ing asthma or COPD according to the Global Initiative for
Asthma (GINA) management [2]. and the Global initiative
for Chronic Obstructive Lung Disease (GOLD) management
[1], respectively.
Initially, the use of inhalation devices was evaluated in a
practical manner, by asking patients to demonstrate their inha-
ler technique with a placebo device. A trained pulmonary
physician acquainted with proper use of inhaler devices and
on how to score each step of the inhalation process audited
the patient inhalation technique. The procedure was assessed
through ﬁlling out a checklists form containing all steps for
correct usage of different inhalation devices that has been
validated in the literature for checking the use of such devices
(Tables 3–6) [10–13]. For each inhaler certain steps were consid-
ered necessary for optimal delivery of the active drug into the
lungs, were termed ‘‘essential’’ inhalations steps (see foot notes
of Tables 3–6).
Subsequently, participants were interviewed and demo-
graphic characteristics (age, occupation, diagnosis, treatingphysician specialty, type and place of inhalation device pre-
scribed as well as the duration of its usage) were recorded as
well as questionnaires regarding patient knowledge of inhala-
tion devices were completed (Table 2).
Spacers are seldom used in study populations and therefore
were not included in the study. Some patients were using more
than one type; in these cases the study was conﬁned to one
device only.
Informed consent was obtained and the ethical committee
of the department of Chest Diseases, Ain Shams University
approved the study.
Statistical analysis
Analyses of all checklist items, essential checklist items only
and all essential checklist items correct for each of the inhalers
used are presented. The total score for each inhaler was calcu-
lated by dividing the number of items correctly completed by
the total number of items tested and the result was expressed
as a percentage. Incorrect handling among different inhaler
devices was compared with Mann–Whitney test. Also, incor-
rect handling committed by asthma patients and by the
COPD patients was compared for each device separately using
the Kruskal–Wallis test. Regarding the questionnaire, the
responses obtained in asthma patients were compared to those
obtained in COPD patients using Mann–Whitney test. Also,
the responses obtained among different inhaler devices were
compared with Kruskal–Wallis test. The mean error of steps
was compared among the different devices using the
Kruskal–Wallis test and among each pair of devices using
Mann–Whitney test. Pearson correlation coefﬁcient was used
to test the correlation between the incorrect use of each device
and the answers of the signiﬁcant questions regarding the
Table 2 Percentage of positive responses to questionnaire regarding knowledge of inhalation devices in asthma and COPD.
Questions Positive responses (%) p
Asthma COPD
Q. 1: Do you know how to use the inhaled medication prescribed? 99.7 99.3 0.495
Q. 2: Do you think that inhaled medications yield good results? 92.7 96.7 0.085
Q. 3: Do you think that your inhaler technique or the way you use your inhaled medication is important? 93.4 95.3 0.407
Q. 4: Has your physician taught you how to use your inhaled medication yet? 71.9 64.7 0.102
Q. 5: Has your physician ever observed you using your inhaled medication? 24.1 15.3 0.055
Q. 6: Does your physician re-evaluate how you use your inhaled medication at every medical visit? 9.5 4 0.036
Q. 7: How many times has your physician observed you using your inhaled medication?
(a) Never 75.9 84.7 0.022
(b) Once 22 15.3
(c) Twice or more times 2.1 0
Do Egyptian patients use their inhalers correctly? A checklist auditing for inhalation devices usage techniques 499knowledge of inhalation. The level of statistical signiﬁcance
was set at p< 0.05 for all analyses. Analysis was performed
with statistics software (SPSS version 17, SPSS, Chicago,
Illinois).
Results
Among the 574 recruited patients, 41 were excluded because
they did not fulﬁll the criteria for age or duration of device
usage. Eventually, 533 patients (52.6% males and 47.4%
females) were included in the present study; 71.9% of
them had asthma, while the remaining 28.1% had COPD.
Demographic data and characteristics of patients, inhaled devices,
and treating physicians are listed in Table 1. Pressurized metered
dose inhaler (MDI) was used by 376 (70.5%) patients. While,
dry-powder inhalers (DPIs) as Diskus, aerolizer/handihaler and
turbuhaler were used by 10.5%, 14.1% and 4.9% of patients,
respectively.
The percentages of positive responses to questionnaire
regarding knowledge of inhalation devices in all studied
populations as well as in asthma and COPD groups are shown
in Fig. 1 and Table 2, respectively. The highest positive respon-
se was for the question addressing the knowledge of using pre-
scribed inhaled medication, whereas the least positive response
was for the question addressing the reevaluation performed by
the physician for the patients regarding the correct use of theFigure 1 Percentage of positive responses to questioinhaled medication at every medical visit (99.6%, and 8.3%,
respectively) (Fig. 1). The comparison of the responses
obtained in the asthma and COPD groups revealed signiﬁcant
differences in the responses to two questions (Q.6 and Q.7),
being greater in the asthma group compared to the COPD
group (Table 2).
The overall percentage of the patients made at least one
mistake in their inhalation techniques was 91.7%, while,
35.8% of the patients made at least one essential mistake in
their inhalation technique.
The percentages of mistakes per step in using MDI, Diskus,
aerolizer and handihaler and turbuhaler are shown in Tables 3–
6, respectively. Exhalation to RV was the most frequently
committed mistake in handling of MDI, Diskus and aerolizer/
handihaler. The percentages of mistakes in this step were
83.2%, 55.4% and 66.7%, respectively. While, the most fre-
quently committed error (37.5%) in handling the turbuhaler
was failure to perform the step of ‘‘exhale and wait 20 s for
2nd use’’. The most common mistakes among essential steps
in each device were as follows: the step of slow inhalation and
activation of MDI (34.5%), the 2 essential steps of the Diskus
inhaler (namely the preparation of the Diskus and the forceful
and deep inhalation steps) 3.6% for each step, the forceful and
deep inhalation step of the aerolizer and handihaler (12%),
and the steps of keeping the turbuhaler upright and the rotation
grip anti-clock wise and back until ‘‘click’’ (7.7%, each).nnaire regarding knowledge of inhalation devices.
Table 3 Percentage of mistakes per step of use in metered dose inhaler (MDI).
Questions Mistakes per step (%)
Step 1: Remove the cover 0
Step 2: Shake the inhaler* 15.5
Step 3: Hold inhaler upright 10.9
Step 4: Keep head upright or slightly tilted 33.6
Step 5: Exhale to FRC/RV 83.2
Step 6: Position mouth piece between lips or keep 2–4 cm away 24.3
Step 7: Inhale slowly and activate MDI* 34.5
Step 8: Continue to slow & deep inhalation* 32.4
Step 9: Hold breath for 10 s 24.3
Step 10: Exhale and wait 20 s for 2nd use 45.7
Step 11: Shake the inhaler before 2nd use 47.3
Abbreviation: FRC, functional residual capacity; RV, residual volume.
* Essential steps.
Table 4 Percentage of mistakes per step of use in Diskus.
Questions Mistakes per step (%)
Step 1: Keep Diskus horizontal 7.1
Step 2: Prepare Diskus* 3.6
Step 3: Exhale to FRC/RV 55.4
Step 4: Position mouth piece between lips 0
Step 5: Inhale forcefully and deeply* 3.6
Step 6: Remove the device from mouth before exhale 3.6
Step 7: Hold breath for 10 s 46.4
Step 8: Exhale and wait 20 s for 2nd use 19.6
Abbreviation: FRC, functional residual capacity; RV, residual volume.
* Essential steps.
Table 5 Percentage of mistakes per step of use in aerolizer/handihaler.
Questions Mistakes per step (%)
Step 1: Remove the cover 1.3
Step 2: Keep device horizontal 8
Step 3: Prepare the device (place capsule and perforate)* 2.7
Step 4: Exhale to FRC/RV 66.7
Step 5: Position mouth piece between lips 2.7
Step 6: Inhale forcefully and deeply* 12
Step 7: Remove the device from mouth before exhale 20
Step 8: Hold breath for 10 s 46.7
Step 9: Exhale 38.7
Abbreviation: FRC, functional residual capacity; RV, residual volume.
* Essential steps.
Table 6 Percentage of mistakes per step of use in turbuhaler.
Questions Mistakes per step (%)
Step 1: Remove the cover 0
Step 2: Keep device upright* 7.7
Step 3: Rotate grip anti-clock wise and back until ‘‘click’’* 7.7
Step 4: Exhale to FRC/RV 23.1
Step 5: Position mouth piece between lips 0
Step 6: Inhale forcefully and deeply* 3.8
Step 7: Remove the device from mouth before exhale 3.8
Step 8: Hold breath for 10 s 19.2
Step 9: Exhale and wait 20 s for 2nd use 37.5
Abbreviation: FRC, functional residual capacity; RV, residual volume.
* Essential steps.
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inhaled devices including all steps and essential steps is illus-
trated in Fig. 2. The incorrect use was considered if an error
in at least a single step was done. Among all steps analyzed,
patients committed more errors when using MDI followed
by the aerolizer and handihaler, next to them was the
Diskus, whereas the turbuhaler carried the least incorrect use
(94.1%, 81.3%, 69.9% and 50%, respectively). While, among
essential steps only patients committed more errors when using
MDI, followed by the aerolizer/handihaler, turbuhaler and
ﬁnally the Diskus (44.7%, 20%, 15.4% and 7.1% respectively).
The comparison between the mean error among the different
devices including all steps and essential steps is shown in
Fig. 3, the statistical comparison showed a highly signiﬁcant
difference in the essential steps (p= 0.000). Regarding the
essential steps, patients committed more errors when using
MDI inhalers than when using aerolizer/handihaler, Diskus,
and turbuhaler (p= 0.000, p= 0.000, and p= 0.002, respec-
tively), as well as committing more errors when using aeroliz-
er/handihaler than Diskus (p< 0.05). There was no difference
in the mean essential error committed by the patients between
the Diskus and turbuhaler as well as between the aerolizer/
handihaler and turbuhaler when compared (p= 0.23,
p= 647, respectively).
The percentage of patients with asthma or COPD who
committed at least one essential error when using different
inhalation devices is shown in Table 7. There was a non-sig-
niﬁcant statistical difference between errors committed by
COPD and asthma patients when using MDI or aerolizer/
handihaler. While, statistical comparison for turbuhaler and
Diskus was not possible because of the absence or limited
number of COPD patients using these devices, respectively.
A signiﬁcant negative correlation between answering of
questions regarding physician observation and revaluation of
how they use the inhaler device and incorrect use of Diskus
device only is illustrated in Table 8.
Discussion
This study revealed, that although nearly all patients claimed
to know how to use the inhaled devices prescribed correctly,Figure 2 Correct vs. incorrect usethe fact is that 91.7% and 35.8% of our patients committed
at least one mistake in their inhalation techniques among all
inhalation steps and essential steps audited respectively.
Thus, indicating discrepancy between patients self estimate
and actual usage technique of different inhalation devices.
In the present study, a predeﬁned inhaler-speciﬁc checklist
was used in the evaluation of inhalation technique similar to
other previous studies [10–13]. In order to overcome com-
plexity of simultaneous observing, measuring and judging
inhalation techniques; other investigators used a videotaped
scoring method for auditing the inhalers’ use [14]. Our study,
was an actual clinical practice study auditing proper handling
of inhalation devices in real life unlike controlled clinical trials
which necessitate proper handling of the inhaler devices as an
inclusion criteria before participating in such studies [15,16].
In the current study, >99% of asthma and COPD patients
responded to the questionnaire that they knew how to use the
devices although their technique when actually tested was
unsatisfactory. Similar response was recorded in >98% of
asthma and COPD patients by Souza et al., [17]. This faulty
understanding seems to be responsible for a vicious cycle in
which the patients claim to know how to use inhaler and the
team, believing it to be true, does not test them [17]. This expla-
nation is reinforced by that although 70% of physicians taught
their patients how to use their inhaled medication, only 21%
(22.8% for asthma and 15.3% for COPD) and 8.3% (9.5%
for asthma and 4% for COPD) of current study physicians
observe and most importantly, reevaluate the technique for
using inhalation devices, respectively. Souza et al., 2009 also
found that 66.7% and 26.7% of asthma as well as 40.7% and
17.3% of COPD patients’ physicians respectively observe and
reevaluate the technique for using inhalation devices, respec-
tively. Therefore, concluding that it is not sufﬁcient to ask
patients whether they know how to use inhalation devices
[17]. It is very important that the physicians prescribing aeroso-
lized medication should evaluate their patients’ inhalation tech-
niques regularly since some patients might not perform the
technique properly even after various counseling sessions and
the correct technique can become inadequate over time [18,19].
Inhaler error is well documented. Several studies (spanning
3 decades) found the error rate to be close to, or greater than,among different inhaled devices.
Figure 3 Mean number of errors committed among different inhaled devices.
Table 7 Comparison between asthma and COPD patients who committed at least one essential error when using different inhalation
devices.
Questions Percentage of at least single error in usage
Asthma
(no 383)
COPD
(no 150)
P
Meter dose inhaler 110/250 (44%) 57/126 (45.2%) 0.871
Diskus 4/54 (7.4%) 0/3 (0%) –#
Turbuhaler 4/26 (15.4%) 0/0 (0%) –#
Aerolizer and handihaler 10/53 (18.9%) 5/21 (23.8%) 0.663
# Statistical comparison was not possible because of the absence or limited number of COPD patients using these devices.
Table 8 Correlation between answering of questions regarding physician observation and revaluation of how they use the inhaler
device and incorrect use of each device.
Q.5# Q.6# Q.7#
MDI r 0.027 0.036 0.045
P 0.605 0.485 0.381
Signiﬁcance NS NS NS
Aerolizer/Handihaler r 0.127 0.064 0.083
P 0.279 0.585 0.481
Signiﬁcance NS NS NS
Diskus r 0.325 0.391 0.380
P 0.014 0.003 0.004
Signiﬁcance S HS HS
Turbuhaler r 0.084 0.137 0.107
P 0.698 0.532 0.617
Signiﬁcance NS NS NS
# Refer to Table 2 for detailed questions.
502 A. Madkour, I. Galal90% [17,20,21]. Comparably, 91.7% of our patients showed
incorrect inhalation technique. Focusing on essential steps
seems important because when errors are made regarding these
key steps, it is likely that no or only an insigniﬁcant amount of
medicine will be inhaled [13]. In our study, 35.8% of all asthma
and COPD patients made at least one essential mistake in their
inhalation techniques. Similarly, 40% of patients studied by
either Van der Palen et al. [13] or Rootmensen et al. [14]
recorded at least one essential inhalation mistake among their
participants.
In the current study, a majority (70.5%) of the patients were
using MDI. Being the cheapest inhalation device in the Egyptianmarket and the only inhalation device distributed by state fund-
ed health services may explain this MDI majority use. In this
study, as in others that included patients using different types
of devices either MDI or DPIs, use of an MDI was associated
with a signiﬁcantly higher rate of incorrect technique than differ-
ent DPI devices [11,14,17,22]. In line with previous research,
essential MDI steps concerning hand-lung coordination; that
is, ‘‘activate canister in beginning of slow inhalation’’ and
‘‘continue to inhale slowly and deeply’’, were most frequently
performed incorrectly in the present study [13,14,23,24].
Correct handling of the studied DPI devices was variable.
In agreement with previous reports [13,24], the Diskus had
Do Egyptian patients use their inhalers correctly? A checklist auditing for inhalation devices usage techniques 503the lowest rate of incorrect handling among the DPI devices
studied during auditing the essential inhalation steps. The best
performance of the Diskus in the current study could be
attributed to the assumption that it is the only device found
to have a signiﬁcant negative correlation between its incorrect
use and the physician observation and revaluation of how it is
used. The differences in the handling of DPI devices may be
related to the speciﬁc properties in the design of each device
and the details given in the instructions included in the pack-
age insert of each device [25,26].
There was a non-signiﬁcant statistical difference between
errors committed by the current studied COPD and asthma
patients when using MDI or aerolizer/handihaler.
Rootmensen et al., demonstrated that incorrect inhalation
technique was not related to the type of disease (whether
COPD or asthma) [14]. While, Souza et al., unlikely found that
COPD committed more errors than did those with asthma
among inhaler devices tested. They contributed their ﬁndings
to better care and counseling received by asthmatic patients
and also to differences in patients’ characteristics in each
group. They concluded that further studies are needed to clar-
ify this issue [17].
Mishandling of inhaler technique remains common in real
life for both MDIs and DPIs and is associated with poor clin-
ical control and increased unscheduled health-care resources in
asthma and COPD patients [27]. The major avoidable factor
for improper device use was the lack of education of how
the patient uses the inhaler device correctly. Importantly, we
found that 30% of the patients have not been ever taught
how to use their inhaler devices. Thus, patient education in
proper handling of a prescribed inhaler device should be an
essential part of the pulmonary clinic practice [24].
Finally, it is worth mentioning that the identiﬁcation of pre-
dictors of incorrect inhalation techniques was not investigated
because it was out of the scope of the current study.
Limitations of this study should be noted; sample was enrolled
from 3 Egyptian governorates and therefore the ﬁndings may
not be representative of all Egypt. COPD and asthma patients
as well as different inhaler devices used were not equally dis-
tributed. The presence of more than one observer raises the
possibility of inter-observer variability. Sociodemographic fac-
tors and disease severity were not adjusted initially.
This study shows that improper inhaler technique is com-
mon among asthma and COPD patients in actual Egyptian
pulmonary clinical care practice. Our results revealed inconsis-
tency between patients’ understanding and actual usage tech-
nique of different inhalation devices. Furthermore, larger
national studies are necessary to explore this problem and to
correlate proper handling of inhalers in real practice with clin-
ical efﬁcacy and disease control.Competing interests
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